Ortega-Ramírez MC, Brechtel-Bindel M, González-Dávila J, Fuente-Torres MA

Language: Spanish
References: 18
Page: 17-21
PDF size: 34.34 Kb.

ABSTRACT

The dysthyroid orbitopathy can be associated with thyroid dysfunction, presenting several ophthalmologic alteration mainly optic nerve compressions.
Objective: To correlate visual field abnormalities and clinical manifestation in patients with dysthyroid orbitopathy.
Material and methods: Visual fields blue-yellow and white/white were performed in patients with thyroid ophthalmopathy from May 2001 to May 2002. All patients underwent a complete ophthalmologic evaluation. Ophthalmologic alteration was quantified with Warner‘s classification. Visual field results and clinical sings were compared.
Results: 46 patients were evaluated. Age ranged from 18 to 58 years. Mean visual acuity for both eyes was 20/25. Braily test was positive in 10 patients. Predominant Warner’s classification degrees were 2 and 5. 63% presented alteration in white/white field and 78.3% in the blue/yellow field, 100% of these patients presented soft tissue alterations, proptosis, limited ocular motility in extreme ductions and normal optic nerve.
Conclusions Patients with moderate dysthyroid orbitopathy without clinical optic nerve lesion and normal intraocular pressure presented visual field abnormalities.

REFERENCES

1. Levine MR, Tomsak RL, El-Toukhy E. Thyroid-related ophthalmopathy. Ophthalmol Clin Nor Am 1996; 9(4): 645-658.

2. Espinosa VA. Orbitopatía tiroidea. Primera parte. Rev Mex Oftalmol1999; 73(3):131-141.

3. Igersheimer J. Visual changes in progressive exophthalmos. Arch Ophthalmol 1955; 53:94-104

4. Hedges TR Jr. Scheie HG. Visual field defects in exophthalmos associated with thyroid disease. Arch Ophthalmol 1955; 54:885-892.

5. Haddad HM. Tonography and visual field in endocrine exophthalmos. Report on 29 patients. Am J Ophthalmol 1967; 64:63-67.

6. Sires BS, Orcutt JC. Neuro-ophthalmic aspect of orbital disease. OphthalClin North Am. 1996; 9(4):569-572.

7. Espinosa VA. Orbitopatia tiroidea. Segunda parte. Rev Mex Oftalmol 1999; 73(4):184-190.

8. Spierer A, Eisenstein Z. The role of increased intraocular pressure on upgaze in the assessment of Grave’s Ophthalmopathy. Ophthalmology 1991; 98(10):1491-1494.

9. Cockerham KP, Pal C, Binoy J, Wolter A, Kennerdell JS. The Prevalence and Implications of Ocular Hypertension and Glaucoma in Thyroid-associated Orbitopathy. Ophthalmology 1997; 104(6):914-917.

10. Danks JJ, Harrad RA. Flashing ligas in thyroid eye disease: a new symptom described and (possibly) explained. Br J Ophthalmol 1998; 82:1309-1311.

11. Ohtsuka K, Nakamura Y. Open-angle Galucoma Associated With Graves Disease. Am J Ophthalmol 2000; 129(5):613-617.

12. Kubis KC, Danesh-Meyer H, Pribitkin EA, Bilyk JJ. Progressive Visual Loss and Ophthalmoplegia. Surv Ophthalmol 2000; 44(5):433- 441.

13. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Progression of Early Glaucomatous Visual Field Loss as Detected by Blue- on- Yellow and Estandar White - on- White Automated Perimetry. Arch Ophthalmol 1993; 111:651-656.

14. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Blue-on- Yellow Perimetry Can Predict the Development of Glaucomatous Visual Field Loss. Arch Ophthalmol 1993; 111:645-650.

15. Johnson CA, Brandt JD, Khong AM, Adams AJ. Short- Wavelength Automated Perimetry in Low-Medium, and High-Risk Ocular Hypertensive Eyes. Initial Baseline Result. Arch Ophthalmol 1995; 113:70-76.

16. Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy clinical profile and rationales for management. Arch Ophthalmol 1978; 96(7):1199-1209.

17. Danesh-Meyer H, Savino PJ, Deramo V, Sergott RC, Smith AF. Intraocular presure changes alter treatment for Graves' Orbitopathy. Ophthalmology 2001; 108(1):145-150.

18. Bartley GB, Gorman CA. Diagnostic Criteria for Graves’ Ophthalmopathy. Am J Ophthalmol 1995; 119(6):792-795.